4666 Federal Register / Vol. 87, No. 19 / Friday, January 28, 2022 / Notices 

• NRC’s Agencywide Documents 

Access and Management System 

(ADAMS): You may obtain publicly 

available documents online in the 

ADAMS Public Documents collection at 

https://www.nrc.gov/reading-rm/ 

adams.html. To begin the search, select 

‘‘Begin Web-based ADAMS Search.’’ For 

problems with ADAMS, please contact 

the NRC’s Public Document Room (PDR) 

reference staff at 1–800–397–4209, 301– 

415–4737, or by email to 

PDR.Resource@nrc.gov. For the 

convenience of the reader, instructions 

about obtaining materials referenced in 

this document are provided in the 

‘‘Availability of Documents’’ section. 

• NRC’s PDR: You may examine and 

purchase copies of public documents, 

by appointment, at the NRC’s PDR, 

Room P1 B35, One White Flint North, 

11555 Rockville Pike, Rockville, 

Maryland 20852. To make an 

appointment to visit the PDR, please 

send an email to PDR.Resource@nrc.gov 

or call 1–800–397–4209 or 301–415– 

4737, between 8:00 a.m. and 4:00 p.m. 

(ET), Monday through Friday, except 

Federal holidays. 

FOR FURTHER INFORMATION CONTACT: 

George Alexander, Office of Nuclear 

Material Safety and Safeguards, U.S. 

Nuclear Regulatory Commission, 

Washington, DC 20555–0001; telephone: 

301–415–6755; email: 

George.Alexander@nrc.gov. 

SUPPLEMENTARY INFORMATION: 

I. Background 

The Sigma-Aldrich Company’s 

(Sigma’s) Fort Mims Site is located at 

11542 Fort Mims Drive, Maryland 

Heights, Missouri in a commercial/ 

industrial park. The site consists of a 3- 

acre parcel of land previously used for 

the radiolabeling of chemicals with 

carbon-14 and tritium. 

II. Discussion 

By email dated August 22, 2019, the 

NRC received an application to amend 

Sigma’s decommissioning plan. That 

application was supplemented by letter 

dated April 27, 2020, requesting a 

license amendment for the termination 

of NRC Materials License No. 24– 

16273–01, and by letter dated October 

19, 2020, providing the NRC Form 313 

‘‘Application for Materials License’’ for 

this action. By email dated July 31, 

2020, the NRC staff accepted for 

detailed technical review Sigma’s 

license amendment request to amend 

the decommissioning plan and 

terminate the license. 

The NRC staff reviewed the revised 

decommissioning plan with the sitespecific dose model and license 

termination request. Based on Sigma’s 

dose analysis and the NRC’s 

independent and confirmatory surveys 

and analyses, the NRC staff concluded 

in a safety evaluation report dated 

November 16, 2021, that the Fort Mims 

Site met the dose criteria for 

unrestricted use and that the residual 

radioactivity is as low as reasonably 

achievable, consistent with section 

20.1402 of title 10 of the Code of Federal 

Regulations, ‘‘Radiological criteria for 

unrestricted use.’’ Based on an 

environmental assessment dated 

November 12, 2021, NRC staff 

concluded that there would be no 

significant environmental impacts. 

Accordingly, NRC Materials License No. 

24–16273–01 for the Fort Mims Site was 

terminated. 

III. Availability of Documents 

The documents identified in the 

following table are available to 

interested persons through ADAMS, as 

indicated. 

Document ADAMS 

accession No. 

NRC Approval of Sigma-Aldrich Company’s Fort Mims Facility Decommissioning Plan, dated May 12, 2009 ............................. ML091330309 

Sigma-Aldrich Fort Mims Site Revised Decommissioning Plan, dated June 27, 2019 ................................................................... ML19273A160 

Transmittal Email—Sigma-Aldrich Fort Mims Revised Decommissioning Plan, dated August 22, 2019 ....................................... ML19273A163 

Sigma-Aldrich Fort Mims Site Request for License Termination, dated April 27, 2020 .................................................................. ML20120A544 

Transmittal Email—NRC Acceptance Review of Revised Decommissioning Plan and License Termination Request, dated July 

31, 2020.

ML20213C693 

Sigma-Aldrich Fort Mims Site Revised Decommissioning Plan: NRC Form 313, ‘‘Application for Materials License,’’ dated October 19, 2020.ML20294A191 

NRC Environmental Assessment and Finding of No Significant Impact Related to the Issuance of a License Amendment for 

the Sigma-Aldrich Fort Mims Site, dated November 12, 2021.

ML21277A097 

NRC Safety Evaluation Report of Revised Decommissioning Plan and License Termination Request for the Sigma-Aldrich 

Fort Mims Site, dated November 16, 2021.

ML21300A384 

NRC Materials License 24–16273–01 Termination Amendment 21, dated November 16, 2021 ................................................... ML21300A383 

Dated: January 25, 2022. 

For the Nuclear Regulatory Commission. 

Randolph W. Von Till, 

Chief, Uranium Recovery and Materials 

Decommissioning Branch, Division of 

Decommissioning, Uranium Recovery and 

Waste Programs, Office of Nuclear Material 

Safety and Safeguards. 

[FR Doc. 2022–01754 Filed 1–27–22; 8:45 am] 

BILLING CODE 7590–01–P 

NUCLEAR REGULATORY 

COMMISSION 

[NRC–2022–0001] 

Sunshine Act Meetings 

TIME AND DATE: Weeks of January 31, 

February 7, 14, 21, 28, March 7, 2022. 

PLACE: Commissioners’ Conference 

Room, 11555 Rockville Pike, Rockville, 

Maryland. 

STATUS: Public. 

Week of January 31, 2022 

There are no meetings scheduled for 

the week of January 31, 2022. 

Week of February 7, 2022—Tentative 

Tuesday, February 8, 2022 

10:00 a.m. Meeting with the 

Organization of Agreement States 

and the Conference of Radiation 

Control Program Directors (Public 

Meeting); (Contact: Celimar 

Valentin-Rodriguez: 301–415– 

7124). 

Additional Information: The public is 

invited to attend the Commission’s 

meeting live by webcast at the Web 

address—https://video.nrc.gov/. For 

those who would like to attend in 

person, note that all visitors are required 

to complete the NRC Self-Health 

Assessment and Certification of 

Vaccination forms. Visitors who certify 


jspears on DSK121TN23PROD with NOTICES1
Federal Register / Vol. 87, No. 19 / Friday, January 28, 2022 / Notices 4667 

that they are not fully vaccinated or 

decline to complete the certification 

must have proof of a negative Food and 

Drug Administration-approved 

polymerase chain reaction (PCR) or 

Antigen (including rapid tests) COVID– 

19 test specimen collection from no 

later than the previous 3 days prior to 

entry to an NRC facility. The forms and 

additional information can be found 

here https://www.nrc.gov/about-nrc/ 

covid-19/guidance-for-visitors-to-nrcfacilities.pdf. 

Week of February 14, 2022—Tentative 

There are no meetings scheduled for 

the week of February 14, 2022. 

Week of February 21, 2022—Tentative 

Thursday, February 24, 2022 

10:00 a.m. Briefing on Regulatory 

Research Program Activities (Public 

Meeting); (Contact: Nick 

Difrancesco: 301–415–1115). 

Additional Information: The public is 

invited to attend the Commission’s 

meeting live by webcast at the Web 

address—https://video.nrc.gov/. For 

those who would like to attend in 

person, note that all visitors are required 

to complete the NRC Self-Health 

Assessment and Certification of 

Vaccination forms. Visitors who certify 

that they are not fully vaccinated or 

decline to complete the certification 

must have proof of a negative Food and 

Drug Administration-approved 

polymerase chain reaction (PCR) or 

Antigen (including rapid tests) COVID– 

19 test specimen collection from no 

later than the previous 3 days prior to 

entry to an NRC facility. The forms and 

additional information can be found 

here https://www.nrc.gov/about-nrc/ 

covid-19/guidance-for-visitors-to-nrcfacilities.pdf. 

Week of February 28, 2022—Tentative 

There are no meetings scheduled for 

the week of February 28, 2022. 

Week of March 7, 2022—Tentative 

There are no meetings scheduled for 

the week of March 7, 2022. 

CONTACT PERSON FOR MORE INFORMATION: 

For more information or to verify the 

status of meetings, contact Wesley Held 

at 301–287–3591 or via email at 

Wesley.Held@nrc.gov. The schedule for 

Commission meetings is subject to 

change on short notice. 

The NRC Commission Meeting 

Schedule can be found on the internet 

at: https://www.nrc.gov/public-involve/ 

public-meetings/schedule.html. 

The NRC provides reasonable 

accommodation to individuals with 

disabilities where appropriate. If you 

need a reasonable accommodation to 

participate in these public meetings or 

need this meeting notice or the 

transcript or other information from the 

public meetings in another format (e.g., 

braille, large print), please notify Anne 

Silk, NRC Disability Program Specialist, 

at 301–287–0745, by videophone at 

240–428–3217, or by email at 

Anne.Silk@nrc.gov. Determinations on 

requests for reasonable accommodation 

will be made on a case-by-case basis. 

Members of the public may request to 

receive this information electronically. 

If you would like to be added to the 

distribution, please contact the Nuclear 

Regulatory Commission, Office of the 

Secretary, Washington, DC 20555, at 

301–415–1969, or by email at 

Tyesha.Bush@nrc.gov or Betty.Thweatt@

nrc.gov. 

The NRC is holding the meetings 

under the authority of the Government 

in the Sunshine Act, 5 U.S.C. 552b. 

Dated: January 26, 2022. 

For the Nuclear Regulatory Commission. 

Wesley W. Held, 

Policy Coordinator, Office of the Secretary. 

[FR Doc. 2022–01953 Filed 1–26–22; 4:15 pm] 

BILLING CODE 7590–01–P 

PENSION BENEFIT GUARANTY 

CORPORATION 

Proposed Submission of Information 

Collection for OMB Review; Comment 

Request; Medical Exception Request 

AGENCY: Pension Benefit Guaranty 

Corporation. 

ACTION: Notice of intent to request 

extension of OMB approval of 

information collection. 

SUMMARY: The Pension Benefit Guaranty 

Corporation (PBGC) intends to request 

that the Office of Management and 

Budget (OMB) extend approval, without 

change, under the Paperwork Reduction 

Act, of a collection of information for its 

employees to request a medical 

exception to the COVID–19 vaccination 

requirement. 

DATES: Comments must be submitted on 

or before March 29, 2022. 

ADDRESSES: Comments may be 

submitted by any of the following 

methods: 

• Federal eRulemaking Portal: http:// 

www.regulations.gov. Follow the 

instructions for submitting comments. 

• Email: paperwork.comments@

pbgc.gov. Refer to OMB control number 

1212–0075 in the subject line. 

• Mail or Hand Delivery: Regulatory 

Affairs Division, Office of the General 

Counsel, Pension Benefit Guaranty 

Corporation, 1200 K Street NW, 

Washington, DC 20005–4026. 

Commenters are strongly encouraged 

to submit public comments 

electronically. PBGC expects to have 

limited personnel available to process 

public comments that are submitted on 

paper through mail. Until further notice, 

any comments submitted on paper will 

be considered to the extent practicable. 

All submissions received must 

include the agency’s name (Pension 

Benefit Guaranty Corporation, or PBGC) 

and refer to OMB control number 1212– 

0075. All comments received will be 

posted without change to PBGC’s 

website, http://www.pbgc.gov, including 

any personal information provided. 

Commenters should not include any 

information for which disclosure is 

restricted by statute, such as trade 

secrets and commercial or financial 

information (‘‘confidential business 

information’’). Submission of 

confidential business information 

without a request for protected 

treatment constitutes a waiver of any 

claims of confidentiality. 

Copies of the collection of 

information may be obtained by writing 

to Disclosure Division, Office of the 

General Counsel, Pension Benefit 

Guaranty Corporation, 1200 K Street 

NW, Washington, DC 20005–4026, or 

calling 202–229–4040 during normal 

business hours. TTY users may call the 

Federal Relay Service toll-free at 800– 

877–8339 and ask to be connected to 

202–229–4040. 

FOR FURTHER INFORMATION CONTACT: 

Melissa Rifkin (rifkin.melissa@

pbgc.gov), Attorney, Regulatory Affairs 

Division, Office of the General Counsel, 

Pension Benefit Guaranty Corporation, 

1200 K Street NW, Washington, DC 

20005–4026; 202–229–6563. (TTY and 

TDD users may call the Federal relay 

service toll-free at 800–877–8339 and 

ask to be connected to 202–229–6563.) 

SUPPLEMENTARY INFORMATION: Under 

Executive Order 14043, every Federal 

agency must ‘‘implement, to the extent 

consistent with applicable law, a 

program to require COVID–19 

vaccination for all of its Federal 

employees, with exceptions only as 

required by law.’’ In following this 

directive, the Pension Benefit Guaranty 

Corporation (PBGC) has a requirement 

that its employees must receive and 

submit proof of a COVID–19 

vaccination. As required by 29 U.S.C. 

701 et seq. and 29 CFR part 1630, PBGC 

allows an exception from the 

vaccination requirement for employees 

who demonstrate medical reasons or 

disabilities that would make the 

COVID–19 vaccine unsafe for them. To 


jspears on DSK121TN23PROD with NOTICES1